Your browser doesn't support javascript.
loading
Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease.
Casey, Lara J; Tuttle, Angie; Grabell, Julie; Hopman, Wilma; Moorehead, Paul C; Blanchette, Victor S; Wu, John K; Steele, MacGregor; Klaassen, Robert J; Silva, Mariana; Rand, Margaret L; James, Paula D.
Afiliação
  • Casey LJ; Queen's University, Kingston, Canada.
  • Tuttle A; Queen's University, Kingston, Canada.
  • Grabell J; Queen's University, Kingston, Canada.
  • Hopman W; Queen's University, Kingston, Canada.
  • Moorehead PC; Janeway Children's Health and Rehabilitation Centre, St. John's, Canada.
  • Blanchette VS; Discipline of Pediatrics, Faculty of Medicine, Memorial University, St. John's, Canada.
  • Wu JK; Division of Hematology/Oncology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, Canada.
  • Steele M; British Columbia Children's Hospital, Vancouver, Canada.
  • Klaassen RJ; Alberta Children's Hospital, Calgary, Canada.
  • Silva M; Children's Hospital of Eastern Ontario, Ottawa, Canada.
  • Rand ML; Queen's University, Kingston, Canada.
  • James PD; Division of Hematology/Oncology and Program in Experimental Medicine, The Hospital for Sick Children.
Pediatr Blood Cancer ; 64(10)2017 Oct.
Article em En | MEDLINE | ID: mdl-28453185
ABSTRACT

OBJECTIVE:

Our objective was to generate, optimize, and validate a self-administered pediatric bleeding questionnaire (Self-PBQ) as a screening tool for von Willebrand disease (VWD) in children referred to the hematology clinic for the first time. STUDY

DESIGN:

The Self-PBQ was generated by combining the validated expert-administered PBQ and the International Society on Thrombosis and Hemostasis (ISTH) bleeding assessment tool (BAT). Medical terminology was translated into lay language requiring a grade 4 reading level. In Phase 1, the Self-PBQ was optimized and the level of agreement between the Self-PBQ and the expert-administered PBQ was determined. Phase 2 established the normal range of bleeding scores (BSs) of the Self-PBQ. Phase 3 examined the Self-PBQ as a screening tool for first-time referrals to the hematology clinic.

RESULTS:

The Self-PBQ is a reliable surrogate for the expert-administered PBQ with an excellent intraclass correlation (ICC) of 0.917. The Self-PBQ was scored with the PBQ and the ISTH-BAT scoring systems, for which its normal BS ranges are -1 to 2 or 0 to 2, respectively. A positive Self-PBQ BS (≥3) had a sensitivity of 78%, a specificity of 37%, a positive predictive value of 0.18, and a negative predictive value of 0.91 for identifying VWD in children being investigated by a hematologist for a bleeding disorder.

CONCLUSION:

The Self-PBQ generates comparable BSs to the expert-administered PBQ and is a reliable, reasonably sensitive screening tool to incorporate into the assessment of children presenting to a hematologist for the investigation of an inherited bleeding disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Inquéritos e Questionários / Autorrelato / Hemorragia Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Inquéritos e Questionários / Autorrelato / Hemorragia Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2017 Tipo de documento: Article